Loading insider details...
Beta
Latest Form 4 (Aug 14, 2026): Exercise/Conversion of 15,000 DNTH shares, $272.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 15,000 | $272.6K |
| Aug 11, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 3,833 | $68.5K |
| Jun 18, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 30,000 | $536.4K |
| Feb 4, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 100,000 | n/a |
| Feb 4, 2025 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 100,000 | n/a |
| May 29, 2024 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 75,000 | n/a |
| Jan 26, 2024 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 110,000 | n/a |